天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

2(3H)-Benzoxazolone, 3-[(3-methoxyphenyl)methyl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)-

2(3H)-Benzoxazolone, 3-[(3-methoxyphenyl)methyl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)- ??? ???
?? ??:
2754265-66-0
???:
2(3H)-Benzoxazolone, 3-[(3-methoxyphenyl)methyl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)-
???(??):
TNIK-IN-5;3-(3-methoxybenzyl)-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)benzo[d]oxazol-2(3H)-one;3-(3-methoxybenzyl)-6-(3H-pyrrolo[2,3-b]pyridin-5-yl)benzo[d]oxazol-2(3H)-one;2(3H)-Benzoxazolone, 3-[(3-methoxyphenyl)methyl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)-;inhibit,Colorectal cancer,TNIK,Wnt,Cell proliferation,Inhibitor,TNIKIN5,Wnt pathway,Migration,HCT116?cells,TNIK IN 5
CBNumber:
CB011553320
???:
C22H17N3O3
??? ??:
371.39
MOL ??:
2754265-66-0.mol

2(3H)-Benzoxazolone, 3-[(3-methoxyphenyl)methyl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)- ??

??
1.373±0.06 g/cm3(Predicted)
?? ?? (pKa)
13.56±0.40(Predicted)
??? ??
Solid
??
White to light yellow

??

2(3H)-Benzoxazolone, 3-[(3-methoxyphenyl)methyl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)- C??? ??, ??, ??

2(3H)-Benzoxazolone, 3-[(3-methoxyphenyl)methyl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)- ?? ?? ? ???

???

?? ??


2(3H)-Benzoxazolone, 3-[(3-methoxyphenyl)methyl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)- ?? ??

???( 10)?? ??
??? ?? ??? ?? ?? ? ??
Tianjin Kailiqi Biotechnology Co., Ltd. 15076683720
klq@cw-bio.com China 5944 55
Bide Pharmatech Ltd. 400-1647117 13681763483
product02@bidepharm.com China 62075 58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd. +86-027-59232304 15387063101
2881924050@qq.com China 9998 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24644 58
Beijing Yusheng Chemical Co., Ltd. 17777863707
17777863707@189.cn China 496 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
customer_service@efebio.com China 11974 58

sangon@qq.com CHINA 47239 58
Nanjing Shizhou Biology Technology Co.,Ltd 025-85560043 15850508050
cindy.huang@synzest.com China 12000 58

Copyright 2019 ? ChemicalBook. All rights reserved